Role of lung cancer nurse specialists in recruiting patients to clinical trials
John McPhelim Lead lung cancer nurse, Hairmyres Hospital, Glasgow
Educating patients and their carers about the potential benefits and drawbacks of taking part in research is vital, says John McPhelim
Facilitating access to anti-cancer treatment is an important factor in improving prognosis for many patients with lung cancer. Lung cancer nurse specialists (LCNSs) play an important role in ensuring that patients are managed optimally, including taking part in clinical trials when appropriate. The aims of the survey reported in this article were to examine the views and activities of LCNSs in the UK in relation to recruitment of patients to clinical trials. In addition, the intention was to identify how many LCNSs were involved in patient recruitment to clinical trials and in what way; the views of LCNSs in relation to lung cancer clinical trials; and whether or not they have a role in facilitating recruitment to clinical trials.
LCNSs surveyed agreed that clinical trials were valuable in developing novel treatment strategies. The results showed that LCNSs play an important part in explaining the risks and benefits of participating in clinical trials to patients, although detailed discussions are generally the remit of specialist research nurses.
Cancer Nursing Practice. 14, 4,22-26. doi: 10.7748/cnp.14.4.22.e1065Correspondence
This article has been subject to double-blind review and checked using antiplagiarism softwareConflict of interest
Wordsmiths International provided medical writing services to the author, which were funded by Boehringer Ingelheim. These services included drafting and subsequent revision of the manuscript under the guidance of the author, who had final responsibility for the manuscript content and made the decision to submit the manuscript for publication
Received: 13 August 2014
Accepted: 01 April 2015